help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
A more recent version of this article appeared on October 1, 2007

Published online before print September 6, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Supplemental Material
Right arrow All Versions of this Article:
ajpath.2007.061164v1
171/4/1153    most recent
Right arrow Bodó, Desmond J. Tobin, York Kamenisch, Tamás Bíró, Mark Berneburg, Wolfgang Funk, and Ralf Paus&journal=amjpathol&volume=0&issue=2007&firstpage=200706116&pages=">Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bodó, E.
Right arrow Articles by Paus, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bodó, E.
Right arrow Articles by Paus, R.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.061164

Accepted for publication July 6, 2007.

Article

Dissecting the Impact of Chemotherapy on the Human Hair Follicle. A Pragmatic in Vitro Assay for Studying the Pathogenesis and Potential Management of Hair Follicle Dystrophy

Eniko Bodó*@, Desmond J. Tobin{dagger}, York Kamenisch{ddagger}, Tamás Bíró{sect}, Mark Berneburg{ddagger}, Wolfgang Funk, and Ralf Paus*

From the Department of Dermatology,* University Hospital Schleswig-Holstein, University of Lübeck, Lübeck, Germany; the Department of Dermatology,{ddagger} Eberhard Karls University, Tübingen, Germany; Klinik Dr. Kozlowski, Munich, Germany; Medical Biosciences Research,{dagger} School of Life Sciences, University of Bradford, Bradford, United Kingdom; and the Department of Physiology,{sect} University of Debrecen, Debrecen, Hungary

@ To whom correspondence should be addressed. E-mail: eniko.bodo{at}uk-sh.de.


  Abstract

Chemotherapy-induced alopecia represents one of the major unresolved problems of clinical oncology. The underlying molecular pathogenesis in humans is virtually unknown because of the lack of adequate research models. Therefore, we have explored whether microdissected, organ-cultured, human scalp hair follicles (HFs) in anagen VI can be exploited for dissecting and manipulating the impact of chemotherapy on human HFs. Here, we show that these organ-cultured HFs respond to a key cyclophosphamide metabolite, 4-hydroperoxycyclophosphamide (4-HC), in a manner that resembles chemotherapy-induced HF dystrophy as it occurs in vivo: namely, 4-HC induced melanin clumping and melanin incontinence, down-regulated keratinocyte proliferation, massively up-regulated apoptosis of hair matrix keratinocytes, prematurely induced catagen, and up-regulated p53. In addition, 4-HC induced DNA oxidation and the mitochondrial DNA common deletion. The organ culture system facilitated the identification of new molecular targets for chemotherapy-induced HF damage by microarray technology (eg, interleukin-8, fibroblast growth factor-18, and glypican 6). It was also used to explore candidate chemotherapy protectants, for which we used the cytoprotective cytokine keratinocyte growth factor as exemplary pilot agent. Thus, this novel system serves as a powerful yet pragmatic tool for dissecting and manipulating the impact of chemotherapy on the human HF.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.